Literature DB >> 1979932

The clinical relevance of multidrug resistance.

W T Bellamy1, W S Dalton, R T Dorr.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1979932     DOI: 10.3109/07357909009012080

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  6 in total

1.  Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.

Authors:  U Mayer; E Wagenaar; J H Beijnen; J W Smit; D K Meijer; J van Asperen; P Borst; A H Schinkel
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.

Authors:  G J Sewell
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

Review 3.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

4.  Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression.

Authors:  J L Moretti; H Azaloux; D Boisseron; J C Kouyoumdjian; J Vilcoq
Journal:  Eur J Nucl Med       Date:  1996-08

5.  Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.

Authors:  L Wang; C P Yang; S B Horwitz; P A Trail; A M Casazza
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.

Authors:  F Loor; D Boesch; C Gavériaux; B Jachez; A Pourtier-Manzanedo; G Emmer
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.